JPWO2020178738A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020178738A5
JPWO2020178738A5 JP2021552598A JP2021552598A JPWO2020178738A5 JP WO2020178738 A5 JPWO2020178738 A5 JP WO2020178738A5 JP 2021552598 A JP2021552598 A JP 2021552598A JP 2021552598 A JP2021552598 A JP 2021552598A JP WO2020178738 A5 JPWO2020178738 A5 JP WO2020178738A5
Authority
JP
Japan
Prior art keywords
amino acid
eso
tcr
acid sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021552598A
Other languages
English (en)
Japanese (ja)
Other versions
JP7748874B2 (ja
JP2022523552A (ja
JP2022523552A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/051807 external-priority patent/WO2020178738A1/en
Publication of JP2022523552A publication Critical patent/JP2022523552A/ja
Publication of JPWO2020178738A5 publication Critical patent/JPWO2020178738A5/ja
Publication of JP2022523552A5 publication Critical patent/JP2022523552A5/ja
Application granted granted Critical
Publication of JP7748874B2 publication Critical patent/JP7748874B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021552598A 2019-03-04 2020-03-03 Ｔ細胞受容体及びその使用方法 Active JP7748874B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962813639P 2019-03-04 2019-03-04
US62/813,639 2019-03-04
PCT/IB2020/051807 WO2020178738A1 (en) 2019-03-04 2020-03-03 T cell receptors and methods of use thereof

Publications (4)

Publication Number Publication Date
JP2022523552A JP2022523552A (ja) 2022-04-25
JPWO2020178738A5 true JPWO2020178738A5 (https=) 2023-03-13
JP2022523552A5 JP2022523552A5 (https=) 2023-03-13
JP7748874B2 JP7748874B2 (ja) 2025-10-03

Family

ID=72336933

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021552598A Active JP7748874B2 (ja) 2019-03-04 2020-03-03 Ｔ細胞受容体及びその使用方法

Country Status (13)

Country Link
US (1) US20220169695A1 (https=)
EP (1) EP3935173A4 (https=)
JP (1) JP7748874B2 (https=)
KR (1) KR20210149051A (https=)
CN (1) CN113853434B (https=)
AU (1) AU2020231106A1 (https=)
BR (1) BR112021017486A2 (https=)
CA (1) CA3132252A1 (https=)
IL (1) IL286032A (https=)
MX (1) MX2021010533A (https=)
SG (1) SG11202109588RA (https=)
TW (1) TWI875737B (https=)
WO (1) WO2020178738A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7748284B2 (ja) 2019-03-04 2025-10-02 ユニバーシティー ヘルス ネットワーク Ｔ細胞受容体及びその使用方法
MX2021010541A (es) 2019-03-04 2021-12-15 Univ Health Network Receptores de linfocitos t y metodos de uso de estos.
CN113795586B (zh) 2019-03-25 2026-03-27 大学健康网络 T细胞受体及其使用方法
WO2022099543A1 (zh) * 2020-11-12 2022-05-19 深圳先进技术研究院 Ny-eso-1基因抑制剂作为抗肿瘤化疗药物增敏剂的应用
CN117843800A (zh) * 2023-12-01 2024-04-09 浙江大学 一种靶向胞内ny-eso-1的双特异抗体及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506875B1 (en) * 2000-09-26 2003-01-14 Ludwig Institute For Cancer Research Isolated peptides which bind to HLA-C molecules and uses thereof
WO2008042407A1 (en) * 2006-10-03 2008-04-10 Ludwig Institute For Cancer Research Melanoma repopulating cells
US8105831B2 (en) * 2007-03-09 2012-01-31 University Of Washington Parvoviral production of HLA homozygous cells
US9051391B2 (en) * 2007-06-11 2015-06-09 Takara Bio Inc. Method for expression of specific gene
ES2635335T3 (es) 2010-09-20 2017-10-03 Biontech Cell & Gene Therapies Gmbh Receptores de células T específicos de antígeno y epítopos de células T
WO2014160030A2 (en) * 2013-03-13 2014-10-02 Health Research, Inc. Compositions and methods for use of recombinant t cell receptors for direct recognition of tumor antigen
AU2015343013B2 (en) * 2014-11-05 2020-07-16 Board Of Regents, The University Of Texas System Gene modified immune effector cells and engineered cells for expansion of immune effector cells
WO2017120428A2 (en) * 2016-01-06 2017-07-13 Health Research, Inc. Compositions and libraries comprising recombinant t-cell receptors and methods of using recombinant t-cell receptors
AU2017226199A1 (en) * 2016-03-04 2018-09-13 New York University Virus vectors expressing multiple epitopes of tumor associated antigens for inducing antitumor immunity

Similar Documents

Publication Publication Date Title
JP2022109953A5 (https=)
JP2020509767A5 (https=)
Spear et al. Strategies to genetically engineer T cells for cancer immunotherapy
US11052138B2 (en) Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors
CN109694854B (zh) 通用型嵌合抗原受体t细胞制备技术
JP2021522820A5 (https=)
Shilyansky et al. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
EP4729532A2 (en) Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
CN112088008A (zh) 修饰细胞的扩增及其用途
Tsang et al. Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.
JP2019519245A5 (https=)
CN114616337A (zh) 嵌合CD3融合蛋白与基于anti-CD3的双特异性T细胞激活元件的联合表达
JP2020533962A5 (https=)
JP2021512637A5 (https=)
WO2022099076A1 (en) Cells comprising t cell-antigen couplers and uses thereof
JPWO2020193767A5 (https=)
JPWO2020194195A5 (https=)
JPWO2020048995A5 (https=)
JPWO2020178739A5 (https=)
JPWO2020178738A5 (https=)
JPWO2020178742A5 (https=)
CN113785064B (zh) T细胞受体及其使用方法
JPWO2020178740A5 (https=)
JPWO2020178741A5 (https=)
JPWO2020178743A5 (https=)